NFATC4 and breast carcinoma: In our present study, we have shown for the first time that EVs originated from NFAT3-expressing poorly aggressive luminal breast cancer cells are competent to alone inhibit triple breast cancer cell lines invasion and, in cooperation with macrophages, spheroids growth in vitro.